Cargando…
A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2
Patient: Male, 57-year-old Final Diagnosis: COVID-19 pneumonia • reinfection Symptoms: Cough • fever Medication: — Clinical Procedure: — Specialty: Infectious Diseases OBJECTIVE: Unusual clinical course BACKGROUND: Coronavirus disease 2019 (COVID-19) has radically changed the world, and promising va...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718490/ https://www.ncbi.nlm.nih.gov/pubmed/33257644 http://dx.doi.org/10.12659/AJCR.927154 |
_version_ | 1783619503743041536 |
---|---|
author | Sharma, Rohit Sardar, Sundus Arshad, Abdullah Mohammad Ata, Fateen Zara, Sabeen Munir, Waqar |
author_facet | Sharma, Rohit Sardar, Sundus Arshad, Abdullah Mohammad Ata, Fateen Zara, Sabeen Munir, Waqar |
author_sort | Sharma, Rohit |
collection | PubMed |
description | Patient: Male, 57-year-old Final Diagnosis: COVID-19 pneumonia • reinfection Symptoms: Cough • fever Medication: — Clinical Procedure: — Specialty: Infectious Diseases OBJECTIVE: Unusual clinical course BACKGROUND: Coronavirus disease 2019 (COVID-19) has radically changed the world, and promising vaccine trials are currently underway. The immune responses in asymptomatic and symptomatic individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are still under investigation, and data are evolving. While it is known that humoral and cell-mediated immune responses against SARS-CoV-2 are elicited, it is uncertain whether these responses protect against reinfection or that they provide definitive evidence of viral clearance. Very few cases have been reported in the literature regarding reinfection with SARS-CoV-2. CASE REPORT: We present a case of a middle-aged man with asymptomatic SARS-CoV-2 infection who later developed mild symptomatic COVID-19 after a period of 3 months. The source of reinfection was likely from the community, which had a soaring burden of infection with the highest number of COVID-19 cases per million in the world at that time. The patient had 2 negative COVID-19 polymerase chain reaction (PCR) tests 2 weeks after the initial infection. During the second infection, a nasopharyngeal reverse-transcription PCR test and tests for the presence of COVID-19 immunoglobulin (Ig)M and IgG antibodies were all positive. CONCLUSIONS: Reinfection with SARS-CoV-2 is a strong possibility. This case raises concerns that asymptomatic infections may not provide long-term protective immunity to all patients, which could make them susceptible to rein-fection. Possible explanations for reinfection include an interval decrease in protective antibodies titers after SARS-CoV-2 infection that may be more prevalent in patients who had an asymptomatic infection. Other possibilities include viral reactivation after a prolonged carriage of the virus or delayed immune response. |
format | Online Article Text |
id | pubmed-7718490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77184902020-12-30 A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2 Sharma, Rohit Sardar, Sundus Arshad, Abdullah Mohammad Ata, Fateen Zara, Sabeen Munir, Waqar Am J Case Rep Articles Patient: Male, 57-year-old Final Diagnosis: COVID-19 pneumonia • reinfection Symptoms: Cough • fever Medication: — Clinical Procedure: — Specialty: Infectious Diseases OBJECTIVE: Unusual clinical course BACKGROUND: Coronavirus disease 2019 (COVID-19) has radically changed the world, and promising vaccine trials are currently underway. The immune responses in asymptomatic and symptomatic individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are still under investigation, and data are evolving. While it is known that humoral and cell-mediated immune responses against SARS-CoV-2 are elicited, it is uncertain whether these responses protect against reinfection or that they provide definitive evidence of viral clearance. Very few cases have been reported in the literature regarding reinfection with SARS-CoV-2. CASE REPORT: We present a case of a middle-aged man with asymptomatic SARS-CoV-2 infection who later developed mild symptomatic COVID-19 after a period of 3 months. The source of reinfection was likely from the community, which had a soaring burden of infection with the highest number of COVID-19 cases per million in the world at that time. The patient had 2 negative COVID-19 polymerase chain reaction (PCR) tests 2 weeks after the initial infection. During the second infection, a nasopharyngeal reverse-transcription PCR test and tests for the presence of COVID-19 immunoglobulin (Ig)M and IgG antibodies were all positive. CONCLUSIONS: Reinfection with SARS-CoV-2 is a strong possibility. This case raises concerns that asymptomatic infections may not provide long-term protective immunity to all patients, which could make them susceptible to rein-fection. Possible explanations for reinfection include an interval decrease in protective antibodies titers after SARS-CoV-2 infection that may be more prevalent in patients who had an asymptomatic infection. Other possibilities include viral reactivation after a prolonged carriage of the virus or delayed immune response. International Scientific Literature, Inc. 2020-12-01 /pmc/articles/PMC7718490/ /pubmed/33257644 http://dx.doi.org/10.12659/AJCR.927154 Text en © Am J Case Rep, 2020 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Articles Sharma, Rohit Sardar, Sundus Arshad, Abdullah Mohammad Ata, Fateen Zara, Sabeen Munir, Waqar A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2 |
title | A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2 |
title_full | A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2 |
title_fullStr | A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2 |
title_full_unstemmed | A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2 |
title_short | A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2 |
title_sort | patient with asymptomatic sars-cov-2 infection who presented 86 days later with covid-19 pneumonia possibly due to reinfection with sars-cov-2 |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718490/ https://www.ncbi.nlm.nih.gov/pubmed/33257644 http://dx.doi.org/10.12659/AJCR.927154 |
work_keys_str_mv | AT sharmarohit apatientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2 AT sardarsundus apatientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2 AT arshadabdullahmohammad apatientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2 AT atafateen apatientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2 AT zarasabeen apatientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2 AT munirwaqar apatientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2 AT sharmarohit patientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2 AT sardarsundus patientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2 AT arshadabdullahmohammad patientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2 AT atafateen patientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2 AT zarasabeen patientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2 AT munirwaqar patientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2 |